logo
Home  > Imidazo[1,2-a]pyridine-2,3-dione,hexahydro-6,7,8-trihydroxy-5-(hydroxymethyl)-, (5R,6R,7S,8R,8aS)-

AW54913

109944-15-2 | Imidazo[1,2-a]pyridine-2,3-dione,hexahydro-6,7,8-trihydroxy-5-(hydroxymethyl)-, (5R,6R,7S,8R,8aS)-

Packsize Purity Availability Price Discounted Price    Quantity
1mg 98% in stock $81.00 $57.00 -   +
5mg 98% in stock $231.00 $162.00 -   +
10mg 98% in stock $335.00 $234.00 -   +
50mg 98% in stock $1,254.00 $878.00 -   +

*All products are for research use only and not intended for human or animal use.

*All prices are in USD.

Description
Catalog Number: AW54913
Chemical Name: Imidazo[1,2-a]pyridine-2,3-dione,hexahydro-6,7,8-trihydroxy-5-(hydroxymethyl)-, (5R,6R,7S,8R,8aS)-
CAS Number: 109944-15-2
Molecular Formula: C8H12N2O6
Molecular Weight: 232.1907
MDL Number: MFCD00270017
SMILES: OC[C@@H]1[C@@H](O)[C@H](O)[C@@H]([C@@H]2N1C(=O)C(=O)N2)O

 

Upstream Synthesis Route
  • Kifunensine is a potent inhibitor of class I alpha-mannosidases, which are enzymes crucial for the processing of N-linked oligosaccharides in glycoproteins. In chemical synthesis, Kifunensine's ability to selectively inhibit these enzymes makes it a valuable tool for controlling glycoprotein structure and function. By using Kifunensine during glycoprotein synthesis, researchers can manipulate the glycosylation patterns of proteins, leading to a better understanding of their biological activities and potential therapeutic applications. This targeted inhibition provided by Kifunensine allows for the production of homogenous glycoproteins with specific glycan structures, opening doors for a wide range of research opportunities in the fields of biochemistry and drug development.
FEATURED PRODUCTS